Securities code: Boya Bio-Pharmaceutical Group Co.Ltd(300294) securities abbreviation: Boya Bio-Pharmaceutical Group Co.Ltd(300294) Announcement No.: 2022019 Boya Bio-Pharmaceutical Group Co.Ltd(300294)
Announcement on completing the registration of company name change and renewing the business license
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) (hereinafter referred to as "the company") held the 13th meeting of the seventh board of directors on January 12, 2022 and the first extraordinary general meeting of shareholders in 2022 on January 28, 2022, respectively, to consider and adopt the proposal on changing the company name, etc. See the relevant announcement disclosed by the company on cninfo.com for details.
Up to now, the company has completed the procedures of name change registration and filing, and obtained the business license renewed by Fuzhou market supervision administration on March 22, 2022. The main information registered in the business license is as follows: Name: China Resources Boya Bio-Pharmaceutical Group Co.Ltd(300294)
Unified social credit Code: 91361 Tpv Technology Co.Ltd(000727) 7556904
Type: other joint stock limited companies (listed)
Legal representative: Liang Xiaoming
Registered capital: five hundred and eleven million six hundred and thirty-three thousand four hundred and thirty-eight yuan only
Date of establishment: November 6, 1993
Business term: November 6, 1993 to long term
Address: No. 333, Huiquan Road, Fuzhou high tech Industrial Development Zone, Fuzhou City, Jiangxi Province
Business scope: licensed items: drug production, entrusted production of drugs, drug import and export, technology import and export, import and export of goods, sales of pharmaceutical raw materials, auxiliary materials and intermediate products (business activities can be carried out only after the approval of relevant departments for projects subject to approval according to law) general items: technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion, socio-economic consulting services, marketing planning, Financial consultation (in addition to the licensed business, it can independently operate projects not prohibited or restricted by laws and regulations)
It is hereby announced.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) board of directors March 22, 2022
